In the News

UVA researchers determined that ACE inhibitors, beta-blockers and thiazide diuretics appear particularly beneficial to patients with colorectal cancer.

UVAToday

University leadership has committed between $20 million and $50 million for research in environmental resilience and neuroscience this academic year.

UVAToday

The Blue Ridge Poison Center, which has received more than 85 calls this year about snakebites, shares tips on how to handle them.

UVAToday

UVA education professor Tish Jennings shares how classroom practices that prioritize safety and community can help schools meet students’ needs this year.

UVAToday

McIntire professor Peter Gray recently took a deep dive into a popular analytics tool that some organizational leaders are using to help them make decisions about employees returning to work.

UVAToday

A preventative drug has been available for more than a decade, yet public health officials estimate that fewer than 20% of people who would benefit from the drug are actually taking it.

UVAToday

Using a telehealth system called “ECHO,” School of Education and Human Development professors Gail Lovette and Rose Nevill have come up with a way to help the caregivers of children with developmen

UVAToday

UVA anthropologists China Scherz and Jarrett Zigon discuss the rise in overdose deaths, offering ideas for understanding this health crisis and different ways of healing.

UVAToday